Cullinan Therapeutics, Inc. CGEM Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s software and technology licenses, net?
- Cullinan Therapeutics, Inc. (CGEM) reported software and technology licenses, net of $297K in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Cullinan Therapeutics, Inc.'s software and technology licenses, net decreased by 18.9% year-over-year, from $366K to $297K.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s software and technology licenses, net has grown at a -33.6% compound annual growth rate (CAGR), from $2.3M to $297K.